Acrylamide is a ubiquitous toxicant in human lives, due to its formation in many food products. Acrylamide induces dominant lethal mutations with administration of 25 mg/kg bw/day for 5 days in male mice. Cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1) is responsible for this dominant lethality. CYP2E1 is the only enzyme responsible for the conversion of acrylamide to the highly reactive metabolite glycidamide, which forms adducts with DNA. CYP2E1 is present predominantly in the liver, as well as the brain, kidney, intestines, and spleen. Within the male mouse reproductive tract, CYP2E1 localizes to spermatocytes. However, embryo resorptions have been demonstrated to occur only with exposure of the late stages of spermatogenesis and spermatozoa. It was determined that CYP2E1 is additionally expressed within the mouse epididymal epithelium, and this localization is responsible for acrylamide-induced dominant lethality. Further, an equivalent profile of CYP2E1 expression was identified in the human reproductive tract. While spermatozoa of both species were also established to possess CYP2E1, this did not contribute to acrylamide-induced DNA damage. In vitro studies strengthened these findings further, revealing that acrylamide exposure only induces DNA damage in human and mouse spermatozoa following metabolism by the mouse epididymal epithelial cell line (mECap18) to glycidamide. These findings emphasize, for the first time, the vital role of the epididymis in the reproductive toxicity associated with acute acrylamide exposure.
Introduction
Acrylamide is known to cause neurotoxicity in humans [1, 2] and is classified as a probable human carcinogen [3] . These effects also manifest in the mouse model (reviewed in Friedman [4] ). Additionally, acrylamide induces reproductive toxicity in male mice (reviewed in Katen and Roman [5] ). The major industrial use for acrylamide is in its polymerized form. Polyacrylamide has widespread applications, including as a grouting agent in tunnel construction [6] , in the cosmetics industry [7] , and in research laboratories for the preparation of polyacrylamide gels for electrophoresis (PAGE) [8] , all of which can result in human exposure to residual quantities of acrylamide. Of greatest concern to human exposure is the presence of acrylamide in a number of food sources as a by-product of cooking at temperatures above 120
• C [9] . Amino acids, particularly asparagine, react with reducing sugars, such as glucose, to form the toxicant via Maillard reactions in carbohydrate-rich foods such as potatoes, cereals, and breads [10] . Acrylamide is also present in cigarettes [8] . Human exposure to acrylamide through food processing is unavoidable with an estimated dietary exposure of 1-4 μg/kg bw/day [11] .
The reproductive toxicity associated with acrylamide occurs predominantly as a result of its conversion to glycidamide, a highly reactive compound with the capacity to form covalent bonds with the nucleotides of DNA. The predominant adducts that form with in vivo treatment of mice and rats are N-7(2-carbamoyl-2-hydroxyethyl)-guanine (N7-GA-guanine) and to a lesser extent N3-(2-carbamoyl-2-hydroxyethyl)-adenine (N3-GA-Ade) [12] . When male mice or rats are administered acrylamide at acute doses and mated with unexposed females, dominant lethal mutations result in embryonic resorptions. Studies have examined the incidence of these embryo resorptions with a specific focus on the effects of exposure to the late stages of spermatogenesis [13] [14] [15] [16] . Indeed, Shelby et al. [16] demonstrated the dominant lethality induced by a single injection of 125 mg/kg bw acrylamide in mice, with significant increases observed when spermatozoa, or spermatid stages were exposed. In marked contrast, earlier stages of spermatogenesis appeared to be unaffected. In addition, Shelby et al [16] demonstrated that treatments of 30 mg/kg bw/day for five consecutive days resulted in a higher incidence of dominant lethality compared to a single 125 mg/kg bw dose. Notably, however, only spermatids and sperm stages were assessed in this study. Similarly, research by Ehling and Neuhäuser-Klaus [15] has also demonstrated the dominant lethality of acrylamide, however only using a single dose of 50, 75, or 100 mg/kg bw.
Ghanayem et al. [17] provided undeniable evidence of the requirement for cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1) in the conversion of acrylamide to glycidamide by administering acrylamide to mice resulting in the formation of glycidamide-hemoglobin adducts in wild-type mice, but not their CYP2E1 null counterparts. Hence, there is no other mechanism for the conversion of acrylamide to glycidamide. They have also demonstrated the necessity of this enzyme in acrylamide-induced germ cell mutagenicity by administering 12.5 and 25 mg/kg bw doses of acrylamide for five consecutive days to wild-type and CYP2E1 null mice [18] . Two-, five-day mating periods (MPs) were established, which focused on late-stage spermatids and spermatozoa. Significant increases in embryo resorptions and decreases in live fetuses were observed in the wild-type mice. This effect was abrogated in the CYP2E1 null mice exposed to acrylamide.
A number of studies add to this evidence that acrylamideinduced dominant lethality is a CYP2E1 and hence glycidamidemediated effect. Generoso et al. [19] demonstrated that dominant lethality accompanies direct glycidamide treatment, which agrees with the results obtained by Shelby et al. [16] and Ehling and Neuhäuser-Klaus [15] . Further to this, Adler et al. [14] demonstrated the importance of the conversion of acrylamide to glycidamide in generating dominant lethality by using a specific inhibitor of CYP2E1; 1-aminobenzotriazole. Three treatments of 50 mg/kg 1-aminobenzotriazole reduced the dominant lethality observed with a single dose of 125 mg/kg bw acrylamide. Later stages of spermatogenesis were most sensitive to the exposure; however, the MPs were not tightly restricted around the transitions between different stages of spermatogenesis, and again acrylamide was only administered once.
To date, the only CYP2E1 localization demonstrated in the reproductive tract of the male mouse is within the testis, in particular in the spermatocytes [20] . Indeed, in vitro acrylamide treatment of spermatocytes [20] and in vivo acrylamide exposure of mice [21] results in glycidamide-DNA adduct formation in spermatocytes as measured by the formamidopyrimidine-DNA glycosylase (FPG)-modified comet assay. Hence, we sought to expand these studies by establishing the localization of CYP2E1 within the testis and epididymis of the mouse and the human. We employed an acute, highdose acrylamide regimen in male mice, equivalent to that utilized by Ghanayem et al. [18] and sufficient to induce dominant lethality. We hypothesized a direct link between the expression profile of the enzyme and the specific stages of spermatogenesis and sperm storage during which acute acrylamide exposure results in dominant lethality.
Methods

Chemicals and reagents
Acrylamide (A3553) was purchased from Sigma (St Louis, MO, USA). Rabbit polyclonal specific anti-CYP2E1 (19937-1-AP) was purchased from Proteintech (Chicago, IL, USA). Alexa Fluor 594 goat anti-rabbit IgG (A11012) was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Refer to Supplementary Table 1 for antibody information. Comet Assay LMAgarose (4250-050-02) was purchased from Trevigen (Gaithersburg, MD, USA). Agarose type VII low gelling temperature (A-4018) was purchased from Sigma. RQ1 RNase-free DNase (M610A) was purchased from Promega (Madison, WI, USA). Dakin slides, fully frosted (G376), were purchased from ProSciTech (Kirwan, QLD, Australia). SYBR Green 1 nucleic acid gel stain (50513) was purchased from Lonza (Rockland, ME, USA). CometSlide 2-well slides were purchased from Trevigen (4250-004-03). DNA repair endonucleases, FPG, and 8-oxoguanine DNA glycosylase (hOGG1) were purchased from New England Biolabs Inc. (Arundel, QLD). Human testis (ab4373, Lot: GR8717-15) and epididymis (ab4326 Lot: GR188784-2) sections were purchased from Abcam (Cambridge, MA, USA). MitoSOX Red and the cell viability stain SYTOX Green were purchased from Thermo Fisher Scientific. The vitality stain, SYTOX Green was purchased from Molecular Probes, Invitrogen, OR, USA. The In Situ Cell Death Detection Kit was purchased from Roche Diagnostics (Basel, Switzerland).
Ethical approval for use of human samples
The experiments described in this study were conducted using human semen samples obtained from a panel of healthy normozoospermic donors in accordance with the University of Newcastle's Human Ethics Committee guidelines (Approval No. H-2013-0134).
Ethical approval for use of mice
Experimental procedures involving animals were conducted in accordance with the policies set out by the Animal Care and Ethics Committee of the University of Newcastle (Ethics Number: A2014-428). All animals were housed under controlled temperature and humidity conditions, 16 h light, 8 h dark, with food and water provided ad libitum. Animals were acclimated for at least 1 week prior to treatment.
Immunofluorescence on tissue sections
After extraction, mouse testes and epididymides were fixed in Bouin's solution, embedded in paraffin wax and sectioned at 5 μm thicknesses. Sections were then deparaffinized and rehydrated before antigen retrieval was performed by incubation with 0.05% trypsin with 0.1% calcium chloride at 37
• C for 20 min. Mouse and commercially purchased human tissue sections were then blocked with 3% bovine serum albumin (BSA) in Phosphate-buffered saline (PBS) with 0.05% Tween-20 (PBST) at room temperature for 1 h. Sections were then incubated with anti-CYP2E1 (1:500 with 1% BSA/PBST) overnight at 4 • C. Sections were then washed and incubated with fluorescent-conjugated secondary antibody, Alexa Fluor 594 goat anti-rabbit IgG (1:200 with 1% BSA/PBST), for 1 h at room temperature. Sections were counterstained with 0.5 μg/ml 4 -6-diamidino-2-phenylindole (DAPI) for 2 min. Slides were mounted in mowiol and observed under fluorescence on an Axio Imager A1 fluorescence microscope (Carl Zeiss MicroImaging Inc., Thornwood, NY, USA). Images were taken using an Olympus DP70 microscope camera (Olympus America, Center Valley, PA, USA).
Spermatozoa isolation from testis, caput, corpus, and cauda
Epididymal spermatozoa were isolated as described by Anderson et al. [22] . After collection, the epididymis was cut into the three regions. Each region, and the testis, was placed in 1 ml 4-(2-hydroxyethyl)- 
Immunofluorescence on isolated cells
Cells were air dried onto slides, permeabilized for 10 min in 0.2% Triton X-100 in PBS at room temperature. Non-specific protein binding was blocked using 3% BSA in PBST for 1 h at room temperature. Slides were incubated with anti-CYP2E1 (1:100 in 1% BSA/PBST) for 1 h at room temperature. Sections were washed and incubated with fluorescent-conjugated secondary antibody, Alexa Fluor 594 goat anti-rabbit IgG (1:200 with 1% BSA/PBST), for 1 h at room temperature. Sections were counterstained with DAPI (0.5 μg/ml) for 2 min, mounted in mowiol, and observed under fluorescence as described for immunofluorescence on tissue sections.
Human sperm preparation
Human spermatozoa were purified using 40 and 80% discontinuous Percoll gradients as described previously [23] . High-quality spermatozoa were recovered from the base of the 80% Percoll fraction and resuspended in a bicarbonate-free non-capacitating form of BWW medium [24] 
4).
Half of the mice (three per treatment group) were euthanized 3-5 days after the last injection and sperm were collected from the vas deferens. This population of sperm would therefore have been exposed to acrylamide while exclusively residing in the epididymis. The remaining mice (three per treatment group) were euthanized 24-26 days after the last injection and sperm were again collected from the vas deferens. These spermatozoa would have been exposed to acrylamide while at the pachytene spermatocyte stage of spermatogenesis.
Study 2
Nine adult male Swiss CD-1 mice were randomly allocated to three treatment groups (three mice per treatment). Mice were administered an i.p. injection of acrylamide at a dose of 12.5 mg or 25 mg/kg bw/day or vehicle alone (PBS) each morning for five consecutive days (injection volume 100 μl). The average weight of males at the beginning of treatment was 37.4 g (SD = 2.2). Body weight was monitored throughout the acrylamide treatment, with the average weight following the final injection being 38.0 g (SD = 2.0). Male mice were then each housed with two adult Swiss CD-1 female mice per MP at the appropriate days after the last injection. This allowed for the fertilizing spermatozoa to have been exposed to acrylamide at different stages during spermatogenesis and posttesticular maturation, either as spermatogonia (MP5), spermatocytes (MP4), spermatids (MP3), testicular sperm (MP2), or epididymal sperm (MP1). The Whitten effect was utilized in all mating studies whereby urine-soaked bedding from male mice was introduced to female cages 3 days prior to cohabitation in order to increase the likelihood of pregnancy. The same males were used throughout the study, mating with a total of 12 females each (two females per MP, with a total five MPs). Female mice were euthanized approximately 13 days after the last day of mating and the uterine contents were examined. The number of live fetuses, embryo resorptions, and dead fetuses were counted. This study was modeled on that performed by Ghanayem et al. [18] with narrower MPs.
Study 3
Eight mice per treatment were administered an i.p. injection of acrylamide at a dose of 25 mg/kg bw/day, or vehicle alone each morning for five consecutive days (injection volume 100 μl). The average weight of males at the beginning of treatment was 38.8 g (SD = 2.5). Male mice were each housed with two adult Swiss CD-1 female mice 5-8 days after treatment so that the fertilizing sperm received their exposure while residing exclusively within the epididymis. Female mice were euthanized approximately 13 days after the last day of mating and the uterine contents were examined. The number of live fetuses, embryo resorptions, and dead fetuses were counted.
Acrylamide treatment
Acrylamide was administered via an i.p. injection once per day for five consecutive days at a concentration based on mouse body weights so that each mouse received a 100 μl injection at a dose of either 12.5 or 25 mg/kg bw/day for study 1, or 25 mg/kg bw/day for studies 2 and 3. All mice were monitored for adverse effects daily during treatment. Based on the formula recommended by the Food and Drug Administration for conversion of mouse no-observed-adverse-effect-level (NOAEL) to human equivalent dose (HED) [25] , we determined the HED of acrylamide for our study to be 1.0 and 2.0 mg/kg bw/day for the mouse doses of 12.5 and 25 mg/kg bw/day, respectively. The dose translation formula is as follows:
The K m factor is calculated by dividing the body weight (kg) by body surface area (BSA) (m 2 ). The mouse Km factor is 3, and the human Km factor is 37 (for a 60 kg person) [25, 26] .
Alkaline comet assay on spermatozoa
The alkaline comet assay measures DNA strand breaks (single and double strand breaks) and alkali-labile sites, a form of genetic damage transformed into strand breaks under alkaline conditions [27] . The alkaline comet assay was therefore performed to detect DNA damage to spermatozoa of mice as well as for purified human spermatozoa as described by Katen et al. [28] . Spermatozoa were diluted 1 × 10 6 cells/ ml in TKB buffer (25 mM Tris-HCl, 150 mM KCl pH 7.5) supplemented with 0.25% Triton X-100, and 10 μl of the suspension was mixed with 70 μl of LMAgarose (4250-050-02, Trevigen). An 80 μl sample of the spermatozoa agarose suspension was then spread onto fully frosted Dakin slides (ProSciTech), which had previously been precoated with 70 μl of 1% low gelling temperature agarose (A4018, Sigma) and allowed to dry. The spermatozoa and agarose mixture was then immediately covered with a coverslip and allowed to solidify at 4 Images were taken using an Olympus DP70 microscope camera (Olympus). The DNA integrity of 50 cells per slide was analyzed using Comet Assay IV software (Perceptive Instruments, Suffolk, UK). The relative fluorescence intensity in the comet "tail" versus total intensity of the comet (Tail DNA %) was used as a measure of DNA damage.
Treatment of mouse spermatozoa
Following euthanasia, the vas deferens was isolated and spermatozoa squeezed out into BWW. Spermatozoa were allowed to swim out for 15 min at 37
• C. Spermatozoa were incubated for 1 h with acrylamide at a final concentration of 10 μM, 100 μM, 1 mM, or 100 mM, or glycidamide at a final concentration of 50 nM, 500 nM, 5 μM, 50 μM, or 500 μM. The highest three doses of glycidamide were half the lowest three doses utilized for acrylamide, since the maximal conversion of acrylamide to glycidamide reported in rodents is 51% [29] . Additional higher and lower doses of acrylamide and glycidamide were also included. A further treatment at the highest dose of acrylamide was incubated for 2 h. Following treatment, cells were pelleted and washed three times in PBS, before undergoing the alkaline comet assay.
mECap18 cell culture and treatment
The SV40-immortalized mouse caput epididymal epithelial (mECap18) cell line were provided by Dr Petra Sipilä (Turku University, Turku, Finland) [30] . mECap18 cells were cultured in DMEM (4.5 g/l glucose) supplemented with 100 μM sodium pyruvate, 200 μM L-glutamate, 100 U/ml penicillin, 10 μg/ml streptomycin, and 10% v/v fetal bovine serum with 50 nM 5α-androstan-17β-ol-3-one (7.26 μg/500 ml) with passaging as required [30] . Prior to treatment, mECap18 cells in 1 ml of media were plated on 6-well plates. Conditioned media was also placed in separate 6-well plates. mECap18 cells, as well as conditioned media, were treated with acrylamide at a final concentration of 10 μM, 1 mM, or 100 mM, or glycidamide 5 μM. All samples were incubated for 2 h at 37
• C, 5% CO 2 . Following treatment, the conditioned media from the treated mECap18 cells was transferred to fresh 6-well plates. Mouse spermatozoa isolated from the caput region of the epididymis or purified human spermatozoa were incubated in the conditioned media, which was either derived from mECap18 cells treated in the presence or absence of acrylamide or glycidamide. The sperm cells were incubated in the conditioned media for 1 h prior to being pelleted, washed in PBS and then embedded in agarose for alkaline comet analysis.
Alkaline formamidopyrimidine-DNA glycosylase/8-oxoguanine DNA glycosylase comet assay on mECap18 cells
Following 2 h incubation at a final concentration of 10 μM, 1 mM, or 100 mM, or glycidamide 5 μM, or 5 min 500 μM, mECap18 cells were washed, pelleted, and resuspended in PBS at a concentration of 500 cells/μl. The FPG/hOGG1-modified comet assay was performed as described by Nixon et al. [20] for spermatocytes. Ten microliters of cells in PBS were mixed with 40 μl 0.5% w/v Agarose type VII low gelling temperature (A-4018, Sigma) and layered onto Trevigen comet slides. Agarose was allowed to set at 4
• C, and then slides were immersed in fresh lysis solution (2.5 M NaCl, 100 mM Na 2 EDTA, 10 mM Trizma, and 1% v/v Triton X-100 at pH 10) for 1 h at 4
• C. Dithiothreitol (10 mM final concentration) was then added to the lysis solution and slides were incubated for a further 30 min at 4 buffer for 5 min. Electrophoresis was carried out for 5 min at 0.9 V/cm, 300 mA in alkaline electrophoresis buffer (0.3 M NaOH, 1 mM EDTA), after which slides were incubated in neutralization solution (0.4 M Tris, pH 7.5). Slides were stained with SYBR green, visualized under fluorescence, and analyzed as described for the sperm comet assay
Mitochondrial superoxide generation
Mitochondrial reactive oxygen species (ROS) generation in live cells was measured as described previously [31] . MitoSOX Red and the cell viability stain SYTOX Green were added to 1 × 10 6 spermatozoa to give final concentrations of 2 and 0.5 μM, respectively. Cells were incubated for 15 min at 37
• C in the dark and then centrifuged at 500 × g; and cell pellets were resuspended in BWW/PVA for analysis on a FACSCalibur flow cytometer (Becton Dickinson).
Cellular reactive oxygen species generation
The Dihydroethidium (DHE) assay was performed as described previously [32] . DHE and the cell viability stain, SYTOX Green, were diluted in BWW/PVA and added to 1 × 10 6 spermatozoa to give final concentrations of 2 and 0.5 μM, respectively. The cells were then incubated in the dark at 37
• C for 15 min and cell pellets were resuspended in BWW/PVA for analysis on a FACSCalibur flow cytometer (Becton Dickinson).
Analysis by flow cytometry
Flow cytometry analysis was performed as described previously [32] .
Statistics
Statistical analyses were performed using JMP software Version 11 (SAS Institute, Cary, NC). All results were tested for normality using the Shapiro-Wilk test. When data were not from the Gaussian distribution, then a posthoc Steel-Dwass multiple comparisons test was used to examine specific significant differences between pairs of groups. When data were from the normal distribution, an analysis of variance was performed followed by All Pairs Tukey HSD to examine differences between pairs. A 5% rejection index of null hypothesis was applied to all tests performed.
Results
CYP2E1 is expressed in spermatocytes, spermatozoa, and in the principal cells of the epididymis CYP2E1 protein was detected in spermatocytes within the testes of mice ( Figure 1A and B) and was undetectable in spermatids. CYP2E1 was present in spermatozoa isolated from the testis as well as in spermatozoa from all regions of the epididymis ( Figure 1C ). Within these cells, CYP2E1 was exclusively localized to the midpiece, suggesting association with the mitochondria. CYP2E1 expression was also strongly detected within the soma of the mouse epididymis (Figure 1A and B) . In this regard, the CYP2E1 protein appeared to be expressed at equivalent levels in all segments of the epididymal tubule, where it was found throughout the cytosol and overlying the nucleus of the principal cells. In contrast, minimal CYP2E1 labeling was detected within the interstitial tissue surrounding the tubules.
CYP2E1 expression is conserved in the human male reproductive tract
Immunofluorescent labeling of human testis ( Figure 2A ) and epididymal tissue ( Figure 2B ) sections with anti-CYP2E1 antibodies confirmed the abundant expression of the enzyme throughout the male reproductive tract. While the quality of the commercial sections used for this purpose precluded the precise staging of CYP2E1 expression profiles during germ cell development, it was nonetheless evident that the protein was present throughout the cytosol and nucleus of the epithelial cells lining the epididymal duct as we previously reported in the mouse ( Figure 1B ). CYP2E1 expression was also prominently detected in the midpiece of ejaculated human spermatozoa ( Figure 2C and D) as well as the lower head region (Figure 2D) .
Sperm DNA damage correlates with localization of CYP2E1 expression in spermatocytes and the epididymis
In study 1, male mice were administered acrylamide or vehicle alone for five consecutive days. These male mice were euthanized in a timedependent manner so that the analyzed spermatozoa were exposed to acrylamide either at the spermatocyte stage of spermatogenesis or during their residence within the epididymal tubule ( Figure 3A ). These developmental stages were targeted due to the elevated levels of CYP2E1 expression detected in the spermatocyte population and within the epididymal epithelium ( Figure 1A and B) . Notably, exposure of developing germ cells during either of these two key phases resulted in highly significant increases in DNA damage as measured by the alkaline comet assay ( Figure 3B and C).
Embryo resorptions correlate with exposure of spermatozoa during storage in the epididymis
Three male mice per group were administered acrylamide at either 12.5, or 25 mg/kg bw/day or vehicle for five consecutive days as outlined in Figure 4A (study 2). These male mice were subsequently mated with two unexposed females per MP for five different MPs. The strict timing of these MPs were selected to ensure that, upon mating the fertilizing spermatozoa would have been exposed to acrylamide at different stages of their development. The percentage of pregnancies recorded were 11/18 (61%), 18/18 (100%), 13/18 (72%), 18/18 (100%), and 16/18 (89%) for MP1 to MP5, respectively. Although not all females became pregnant, this was not entirely unexpected given the short MPs, particularly those employed for MP1. Irrespectively, our data illustrate that all males were fertile and capable of producing multiple pregnancies. The percentages of embryo resorptions arising from these pregnancies were calculated and are represented in Figure 4B . The highest percentage of embryo resorptions was observed after exposure of epididymal spermatozoa to the highest acrylamide dose, and the difference between this and other treatment groups proved to be highly statistically significant (P < 0.0001). As there also appeared to be an increase in embryo resorptions, albeit less pronounced, with spermatocyte exposure (Figure 4B ), this study was repeated for just MPs 1 and 4, with increased numbers of mice (study 3). In this expanded study, embryo resorptions were only induced with acrylamide exposure in MP 1 ( Figure 4C ). No further evidence of embryo resorptions was gleaned for exposure of spermatocytes ( Figure 4D ). 
Direct in vitro acrylamide exposure does not lead to DNA damage in mouse spermatozoa
The CYP2E1 present in spermatozoa could potentially convert acrylamide to glycidamide, resulting in glycidamide-DNA adducts and therefore accounting for the DNA damage documented in these cells. To examine this possibility, acrylamide was administered directly to mouse spermatozoa in vitro at a final concentration of 10 μM, 100 μM, 1 mM, 10 mM, or 100 mM for 1 h. As noted in Figure 5 , none of these treatments elicited DNA damage in spermatozoa as measured by the alkaline comet assay. Extending the exposure period to 2 h also failed to induce DNA damage even at the highest acrylamide dose (100 mM) examined ( Figure 5 ). Conversely, glycidamide treatment occasioned DNA damage at the lowest dose administered; 50 nM, a 2 million fold lower dose than the highest acrylamide dose assessed. Notably, all higher doses of glycidamide examined (500 nM, 5 μM, 50 μM, and 500 μM) also induced sperm DNA damage after only 1 h of treatment. Hence, maximal levels of DNA damage occurred with 50 nM glycidamide treatment for 1 h, while no such damage was detected even after 2 h of 100 mM acrylamide treatment.
Epididymal epithelial cells are required for acrylamide-induced sperm DNA damage
In view of the conflicting data that sperm DNA integrity is not impacted by direct in vitro exposure to acrylamide yet in vivo exposure of epididymal sperm does result in significant DNA damage, we reasoned that the abundant CYP2E1 expressed in the epididymal soma may be responsible for the conversion of acrylamide to its more potent genotoxic metabolite, glycidamide. In order to test this hypothesis, we employed an immortalized mouse caput epididymal (mECap18) cell line that has previously been characterized in relation to its ability to faithfully report normal epididymal gene and protein expression [30] . Prior to use, the presence of CYP2E1 enzyme was examined in mECap18 cells, revealing abundant expression throughout the cytosol and nucleus of a majority of cells ( Figure 6A ) consistent with the localization of the protein in epididymal tissue sections ( Figure 1B) . In order to determine if epiddymal epithelial cells were capable of converting acrylamide to glycidamide, the FPG/hOGG1 modified comet assay was performed on mECap18 cells following in vitro treatment with acrylamide (final concentration 10 μM, 1 mM, or 100 mM) or glycidamide (final concentration 5 μM) for 2 h. The results revealed that acrylamide treatment yielded glycidamide adducts in the cells, as detected using the FPG restriction enzyme ( Figure 6B ). Each dose of acrylamide induced glycidamide adducts, as did direct glycidamide treatment. FPG recognizes DNA adducts and introduces strand breaks at these sites. As this can include oxidative adducts, the hOGG1 endonuclease was also used as it specifically recognizes oxidative DNA adducts, such as 8-oxo-7,8-dihydroguanine (8-oxoGua), an adduct induced by ROS [33] . Each dose of acrylamide induced oxidative adducts; however, the levels of adducts detected using the FPG enzyme far exceeded those detected by hOGG1, hence indicating the presence of glycidamide adducts.
In order to determine if the glycidamide formed by mECap18 cells would indeed damage the DNA of spermatozoa, the mECap18 cells were again treated with acrylamide (final concentration 10 μM, 1 mM, or 100 mM) or glycidamide (final concentration 5 μM), prior to incubation of the conditioned media generated with spermatozoa, as outlined in Figure 7A and B. This experiment incorporated an equivalent conditioned media control that was supplemented directly with acrylamide or glycidamide only after the removal of the mECap18 cells. This experimental design demonstrated that DNA damage was only elicited to spermatozoa when mECap18 cells were present at the time of acrylamide treatment ( Figure 7B ). In contrast, Figure 3 . (A) Adult male mice were administered acrylamide (AA) 25 mg/kg bw/day via an i.p. injection once per day for five consecutive days (study 1). These mice were sacrificed 3-5 days or 24-26 following the last injection, such that the sperm extracted from the vas deferens were exposed to acrylamide as spermatozoa in the epididymis or as spermatocytes. The alkaline comet assay was performed on spermatozoa extracted from the vas deferens of mice exposed as sperm in the epididymis (B) or as spermatocytes (C). Three mice were included per treatment with data presented as percentage increase relative to the control.
glycidamide treatment resulted in a significant elevation of sperm DNA damage irrespective of the presence or absence of the mECap18 cells. On the basis of these data, we infer that the CYP2E1 enzyme expressed in the mECap18 cell line was able to convert acrylamide to glycidamide, which then adducted with the sperm DNA. In contrast, the CYP2E1 in spermatozoa again failed to convert acrylamide to glycidamide, resulting in no DNA damage when sperm were incubated with conditioned media supplemented with acrylamide in the absence of any mECap18 cells. Importantly, this study revealed that human spermatozoa, like that of their mouse counterparts, only incurred DNA damaged when incubated with conditioned media sampled from acrylamide treated mECap18 cells ( Figure 7C ). The human sperm samples did however prove highly vulnerable to DNA damage induced directly by glycidamide ( Figure 7C ). Further evidence that the CYP2E1 in human spermatozoa is inactive is provided in Supplementary Figure S1 . In vitro acrylamide or glycidamide treatment did not induce cellular ROS as measured by the DHE assay, or mitochondrial ROS, as measured using mitoSOX red and assessed in live cells. Together, these findings emphasize the importance of epididymal CYP2E1 enzyme activity in the propagation of acute acrylamide-induced reproductive toxicity in both mouse and humans.
Discussion
The utility of the mouse as a model for understanding acrylamide induced reproductive toxicity in humans
The doses administered to mice in the current study (12.5 and 25 mg/kg bw/day) equate to an HED of 1.0 and 2.0 mg/kg bw/day, which are 250-500 times that of the higher range for human consumption estimates as dictated by the WHO (4 μg/kg bw/day) [11] .
Other sources of acrylamide exposure occur outside of the diet. Cigarette smoking or working with PAGE can introduce an additional exposure of 3.1 and 1.4 μg/kg bw/day, respectively [8] . Therefore, the doses of human exposure will vary greatly between individuals based on dietary practices, as well as lifestyle and occupation. However, the doses of acrylamide utilized in the current study are not reflective of these human exposure estimates. There have been cases assessing the effects of human exposure to very high doses of acrylamide via industrial practices, which result in neurotoxicity [1, 2, [34] [35] [36] [37] . The doses selected in the current study were based on the induction of dominant lethality demonstrated to occur in a dosedependent manner by Ghanayem et al. [18] . By building on their findings regarding the culpability of CYP2E1 in acrylamide-induced dominant lethality; we have now exposed the role of the enzyme specifically within the male reproductive tract. We have highlighted the need to incorporate analysis of epididymal CYP2E1 in chronic studies utilizing human relevant acrylamide doses.
Our data has importantly demonstrated that the expression of CYP2E1 in the mouse mirrors that found in the human male reproductive tract. This provides evidence for the suitability of the mouse for use as a model of acrylamide-induced damage to the germline of humans. CYP2E1 is highly conserved across mammalian species, with an overall amino acid sequence identity of 80% being reported for the mouse and human CYP2E1 homologs [38] . This CYP exists as a single isoform in both the human and mouse, exhibiting similarities in gene expression profiles, substrate specificity, and catalytic activity [39] . Hence, studies of CYP2E1 in mice are highly relevant for the study of environmental and occupational exposure to various xenobiotics. This has allowed studies to extrapolate between the two species, particularly with respect to xenobiotic and drug toxicity [40] . Indeed, the neurotoxic effects caused by acute Figure 4 . (A) Male mice were administered acrylamide (AA) 25 mg/kg bw/day via an i.p. injection once per day for five consecutive days and each male mated with two females per mating period (MP) (study 2). The same male mice were mated with females throughout the study. Approximately 13 days following mating, pregnant females were sacrificed and uterine contents assessed for number of live implants and embryo resorptions. (B) The percentage of embryo resorptions as a result of fertilization by sperm exposed in the vas deferens, epididymis, testis, or as spermatids, spermatocytes or spermatogonia were recorded. The first (C) and fourth (D) MPs were repeated following acrylamide treatment of additional male mice (study 3). Eight males in each treatment were treated with acrylamide and embryo resorptions were assessed in pregnant females 13 days post mating.
and subchronic occupational acrylamide exposure in humans [1, 2] are mirrored in mice (reviewed in [4] ), and the status of acrylamide as a probable human carcinogen is based on studies performed in rodents [3] . Accordingly, numerous studies have utilized rodents as a model for acrylamide-induced reproductive toxicity, neurotoxicity, and carcinogenicity (reviewed in [5] ).
Of particular note are studies of knockout mouse models that have proven highly useful in studying the effects of CYP2E1 metabolism of acrylamide in a context that is directly relevant to humans [17, 18, 41] . Such studies have conclusively demonstrated that glycidamide is responsible for the dominant lethality elicited by acute acrylamide administration in male mice [18] . Further, this model has also established that acrylamide can only be converted to glycidamide via CYP2E1 metabolism [17] . While the CYP2E1 enzyme has previously been detected in spermatocytes [20] , we have now demonstrated the additional localization of CYP2E1 within the principal cells of the mouse epididymis as well as in the midpiece of mature spermatozoa. Notably, the expression pattern of CYP2E1 detected in human male reproductive tissues mirrored that found in the mouse, further strengthening the relevance of the mouse as a model for investigating the clinical significance of CYP2E1 function in the context of male reproductive health. Indeed, given that CYP2E1 was detected in the human testis and epididymis, as well as the midpiece of ejaculated human spermatozoa, each of these sites represents a site for CYP2E1 metabolism of acrylamide to glycidamide. Immunofluorescence was performed on mECap18 cells by incubating with anti-CYP2E1, followed by the appropriate secondary antibody (red) and counterstained with DAPI, shown in blue. Scale bar = 200 μm. (B) mECap18 cells were treated with final concentrations of 10 μM, 1 mM, or 100 mM acrylamide (AA) or 5 μM glycidamide (GA). After 2 h, the cells were washed and the FPG/hOGG1 modified alkaline comet assay was performed. FPG and hOGG1 are restriction enzymes that make the assay specific for measuring glycidamide and oxidative adducts, respectively. The data are representative of the tail intensity normalized to the no enzyme control, and the mean of three biological replicates is displayed. Asterisks indicate significant differences from respective controls.
CYP2E1 expression in spermatocytes
The restricted MPs employed in this study were deliberately chosen so as to enable assessment of differences in vulnerability to acrylamide exposure during key phases of germ cell development. The later stages of sperm development have routinely been the focus for such studies owing to the fact that during these stages, the germ cells have lost their capacity to undergo DNA repair [42, 43] . However, the presence of CYP2E1 in spermatocytes suggests a role of these earlier stage germ cells in propagating acrylamide's reproductive toxicity. Indeed, chronic acrylamide exposure in male mice has Figure 7 . (A) mECap18 cells were treated with final concentrations of 10 μM, 1 mM, or 100 mM acrylamide (AA) or 5 μM glycidamide (GA). After 2 h, the conditioned media from treated mECap18 cells was transferred to fresh wells. Mouse spermatozoa extracted from the caput region of the epididymis, or ejaculated human spermatozoa, were added to the wells containing conditioned media and incubated for 1 h. Additional wells with spermatozoa and conditioned media from untreated mECap18 cells were treated with final concentrations of 10 μM, 1 mM, or 100 mM acrylamide or 5 μM glycidamide. Spermatozoa were then isolated and the alkaline comet assay was performed to assess DNA damage in mouse (B) and human (C) spermatozoa. The data are representative of the tail intensity normalized to the control and the mean of three biological replicates is displayed.
been confirmed to elicit DNA damage, appearing in the form of glycidamide adducts, in the spermatocyte population [21] . Additional research has indicated that exposure of pachytene spermatocytes to an acute acrylamide administration can result in a significant, 10-fold increase in the percentage of zygotes carrying cytogenetic defects [44] . Specifically, this study administered a single acrylamide dose that was twice that of the highest dose used in our current study (5 × 50 mg/kg bw/day) and subsequently conducted mating trials 27.5 days after exposure.
We determined that spermatocyte exposure to acrylamide did result in mature spermatozoa that harbored increased levels of DNA damage, thus supporting a role for spermatocytes in acrylamideinduced reproductive toxicity. Notably, this DNA damage burden did not result in embryo resorptions, and therefore poses potential consequences for offspring if not adequately repaired by the oocyte upon fertilization. Previously, chronic acrylamide exposure has been demonstrated to elicit DNA damage in spermatozoa, without resulting in a reduction in fertility or the number of pups born [45] . This insult did, however, lead to increased testicular CYP2E1 expression, increased levels of oxidative damage in the testis and ultimately, increased levels of DNA damage in the untreated F1 mice. These data demonstrate the consequences for future generations when fertilizing spermatozoa carry DNA damage [45] . Here, we have provided further evidence for the role of spermatocytes in CYP2E1-mediated conversion of acrylamide to glycidamide, and resultant DNA damage to the germline. Further to this, we have revealed CYP2E1 expression within the seminiferous tubules of human male testes, establishing the relevance of this enzyme in human acrylamide exposure.
CYP2E1 expression in the epididymis
A number of studies have suggested that post-testicular spermatozoa are most sensitive to acrylamide exposure in terms of resultant dominant lethal mutations [14, 16, 18, 46] . These studies have not definitively demonstrated the sensitivity of particular stages during post-testicular sperm migration, as none have restricted the MPs sufficiently. Allowing only 3 days for mating in our study revealed that epididymal migration is the most sensitive period for acrylamide-induced DNA damage to the spermatozoa. Additionally, this damage results in embryo resorptions following fertilization and implantation. We hypothesized that the presence of CYP2E1 within the epididymal epithelium is therefore responsible for this effect.
Within the epididymis, spermatozoa undergo the final stages of functional maturation, and this is where they gain motility and the capacity to fertilize the oocyte [47] . The presence of CYP2E1 within the epididymis is consistent with the key role of the epididymis in the protection of spermatozoa, as CYP2E1 is a xenobiotic metabolizing enzyme. The epididymis also contains glutathione S-transferase, as well as alcohol dehydrogenase, both of which are known to play a role in detoxification [48] [49] [50] . Studies indicate that the rat epididymis also contains at least two active forms of epoxide hydrolase, which play an important role in detoxifying epoxides that arise from the metabolism of xenobiotic and endogenous compounds [51] . In addition, the epididymis plays a vital role in protection of spermatozoa against excessive ROS, providing an array of enzymatic and non-enzymatic antioxidants [52] . These include indoleamine 2, 3-dioxygenase [53] , superoxide dismutase, glutathione peroxidases [52, 54, 55] , and non-conventional glutathione peroxidase 5. It is therefore interesting that we have found the epididymis to contribute in a negative manner to the spermatozoa since the luminal environment of this specialized region of the male reproductive tract holds a vital role in protecting spermatozoa during transit and storage [51, 56] .
The presence of CYP2E1 in the epididymis has negative implications, which is a common consequence of xenobiotic metabolism. Humans and mice are armed with xenobiotic metabolizing enzymes in order to detoxify many foreign compounds [57] . These enzymes are involved in two distinct phases of detoxification. In phase I, xenobiotics are rendered reactive by adding a functional center into the molecule. In phase II, this intermediate is conjugated, allowing the formation of sufficiently water-soluble excretable products. As a negative consequence, in many cases the reactive metabolite is more harmful than the parent compound, in a process of bioactivation [58, 59] . CYP2E1 is the specific, and unique, enzyme that performs the phase I metabolism of acrylamide to produce glycidamide [17] . As with the metabolites of many other xenobiotics, glycidamide is indeed more reactive, and much more harmful than the original compound. Glycidamide exerts genotoxic effects by covalently binding to adenine and guanine of DNA [60] . CYP2E1 is therefore the gatekeeper for acrylamide-induced reproductive toxicity.
CYP2E1 was specifically found to localize to the epididymal epithelium in all segments of the epididymis. CYP2E1 was localized to the principal cells, which hold a key role in regulation of the luminal microenvironment via their combined secretory and absorptive activity [61] . Upon exposure, acrylamide readily distributes throughout the body of mice. Acrylamide has a high affinity for germinal tissues and spreads to the testis and epididymis within an hour of oral administration [62] . The epididymis has a blood epididymis barrier (junctions between epithelial principal cells) (BEB) that serves to protect sperm from the immune system and ensures the provision of a unique microenvironment for the promotion of sperm maturation and storage [63] . The BEB comprises tight junction mesh networks that are more extensive in the caput, and less so in the caudal segments [64] . It has been demonstrated, via micropuncture studies, that low molecular weight molecules such as water (18.02 g/mol) and urea (60.06 g/mol) pass freely into the epididymal lumen from the blood with any molecules larger than 160 kDa failing to enter [65] [66] [67] [68] . We propose that acrylamide reaches the epithelial cells of the epididymis, where it is converted by CYP2E1 to glycidamide. We have now demonstrated that mECap18 cells are capable of acrylamide metabolism to glycidamide. With its low molecular weight of just 87.08 g/mol, and its hydrophilic nature, the glycidamide so formed would then readily pass into the lumen where it could adduct with the DNA of the transiting/stored spermatozoa. While we have not established which cell type expressed CYP2E1 protein within the human epididymis, the protein expression we observed does appear to be present in a majority of the somatic cells surrounding the lumen. This suggests that similarly to the mouse, acrylamide would be converted to glycidamide in close proximity to transiting/stored spermatozoa.
CYP2E1 in spermatozoa
It has previously been established that Cyp2e1 mRNA is present predominantly within the spermatogonia of mice, while the protein is only expressed specifically in spermatocytes, with later stage germ cells lacking the gene or protein expression [20] . Translational repression often occurs during spermatogenesis, with synthesis and storage of mRNAs prior to their translation being a necessary feature in spermiogenesis, as global transcription ceases toward the end of this process (reviewed in [69] ). It is therefore intriguing that we have detected CYP2E1 in mature spermatozoa. At this stage of development, the protein is exclusively packaged within the midpiece, and thus presumably the mitochondria, of the cell. Our data demonstrate that, although there is CYP2E1 present within spermatozoa, in its confined location it does not contribute to acrylamide-induced damage to the nuclear DNA of the cell. We have clearly confirmed that acrylamide exposure at all stages of sperm development do not result in equivalent levels of embryo resorptions. Spermatozoa exposed while in the testis did not result in embryo resorptions. In marked contrast, those sperm residing in the epididymis at the time of exposure did induce significant embryo resorptions. These data further emphasize the critical role of the epididymal CYP2E1 in acrylamide-induced DNA damage to spermatozoa. Additionally, directly treating spermatozoa for 1 or 2 h in vitro with 100 mM acrylamide failed to induce DNA damage in these cells. If a sufficient amount of this high dose of acrylamide successfully converted to at least 50 nM of glycidamide by the CYP2E1 harbored within the spermatozoa, then this dose should have been sufficient to elicit DNA damage, as was the case when 50 nM glycidamide was administered to spermatozoa. Collectively, these data support the tenet that it is the presence of CYP2E1 in the epididymis that has significant consequences for the DNA integrity of the spermatozoa. This notion was further reinforced through the use of conditioned medium sampled from a culture of epididymal epithelial cells (mECap18) treated with acrylamide in vitro. The ability of this medium to induce significant DNA damage in both mouse and human spermatozoa argues that epididymal cells are indeed able to affect the conversion acrylamide to glycidamide and subsequently release this genotoxic agent into the external milieu. Importantly, the FPG-modified comet assay revealed that mECap18 cells are capable of producing glycidamide from acrylamide. We propose that some of this glycidamide enters the lumen and induces the DNA damage observed in both human and mouse spermatozoa.
Such pronounced differences in CYP2E1 activity in spermatozoa versus that of epididymal epithelial cells may be attributed, at least in part, to the subcellular localization of the enzyme. In this context, CYP2E1 is exclusively localized to the midpiece of mature spermatozoa, suggesting it is packaged within the mitochondria, rather than the endoplasmic reticulum, as has been reported for other proteins during spermatogenesis. For instance, in early round spermatids of the mouse, phospholipid hydroperoxide glutathioneperoxidase is distributed in the cytoplasm, while in elongated spermatids and mature spermatozoa, its localization becomes restricted to the midpiece [70] . This localization is consistent with that demonstrated in the spermatozoa of a number of other species, including the human. Hartman et al. [71] demonstrated that subcellular localization of CYP2E1 results in differences in enzyme activity with different substrates. Indeed, mitochondrial CYP2E1 is more potent in inducing ROS and oxidative stress than microsomal CYP2E1 [72] . In contrast, our study suggests that CYP2E1 from the endoplasmic reticulum is more potent in affecting acrylamide metabolism to glycidamide. Indeed, the supplementary data demonstrate no detectable activity of mitochondrial CYP2E1 in human spermatozoa following acrylamide treatment, as there was no generation of mitochondrial or cellular ROS.
Overall, this study supports the findings that acrylamide-induced dominant lethality is elicited by the DNA-reactive metabolite glycidamide. Notably, expression of CYP2E1 has been detected within the germ cells of the testis and novel expression identified in the somatic cells of the epididymis, as well as the spermatozoa of both humans and mice. The epididymal CYP2E1 expression coincides with the specific site at which we document major increases in DNA damage to spermatozoa and resultant dominant lethality following acute acrylamide exposure. In conclusion, these data identify the epididymis as the major site of acute acrylamide-induced sperm DNA damage.
Supplementary data
Supplementary data are available at BIOLRE online.
Supplementary Table 1 . Antibody information including Research Resource Identifiers (RRID).
Supplemental Figure S1 . Analysis of the effect of 2 h treatment of human spermatozoa with acrylamide or glycidamide in terms of (A) mitochondrial ROS generation measured with MitoSOX TM Red (MSR) and (B) total cellular ROS generation with dihydroethidium (DHE). Data are presented as the percentage of the live cell population which were positive for MSR or DHE and are the average of 6 biological replicates.
